Orbimed Advisors LLC Spring Works Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

$4.44 Billion
Q1 2024

A detailed history of Orbimed Advisors LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 1,707,331 shares of SWTX stock, worth $64.3 Million. This represents 1.89% of its overall portfolio holdings.

Number of Shares

1,707,331

Previous 3,219,359 46.97%

Holding current value

$64.3 Million

Previous $118 Million 28.49%

% of portfolio

1.89%

Previous 2.88%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$36.5 - $52.5 $55.2 Million - $79.4 Million	-1,512,028 Reduced 46.97%	1,707,331 $84 Million
Q4 2023 Feb 14, 2024	SELL	$18.94 - $37.24 $14.2 Million - $27.9 Million	-749,229 Reduced 18.88%	3,219,359 $118 Million
Q3 2023 Nov 14, 2023	SELL	$23.12 - $31.38 $4.86 Million - $6.59 Million	-210,000 Reduced 5.03%	3,968,588 $91.8 Million
Q2 2023 Aug 14, 2023	SELL	$23.15 - $32.71 $7.42 Million - $10.5 Million	-320,312 Reduced 7.12%	4,178,588 $110 Million
Q1 2023 May 15, 2023	SELL	$24.97 - $34.05 $18.8 Million - $25.6 Million	-751,100 Reduced 14.31%	4,498,900 $116 Million

Q4 2022 Feb 14, 2023	SELL	$21.73 - $28.72 $6 Million - $7.92 Million	-275,926 Reduced 4.99%	5,250,000 $137 Million
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $12.1 Million - $19.9 Million	-502,381 Reduced 8.33%	5,525,926 $158 Million
Q3 2021 Nov 15, 2021	SELL	$62.66 - $88.26 $999,990 - $1.41 Million	-15,959 Reduced 0.26%	6,028,307 $382 Million
Q2 2021 Aug 16, 2021	SELL	$67.45 - $85.63 $9.58 Million - $12.2 Million	-142,041 Reduced 2.3%	6,044,266 $498 Million
Q1 2021 May 17, 2021	SELL	$65.1 - $93.59 $79.4 Million - $114 Million	-1,220,000 Reduced 16.47%	6,186,307 $455 Million
Q3 2019 Nov 14, 2019	BUY	$18.8 - $27.82 $139 Million - $206 Million	7,406,307 New	7,406,307 $161 Million

Others Institutions Holding SWTX

# of Institutions

234

Shares Held

67.7M

Call Options Held

546K

Put Options Held

29.4K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.35B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Spring Works Therapeutics, Inc. Transaction History